PTS Panels Creatinine test strips. PTS Panels Creatinine Test Strips are intended to measure creatinine in whole blood. Creatinine measurements are used in the diagnosis and treatment of renal (kidney) diseases and in the monitoring of renal dialysis. This system is intended for the professional use for accurately and reproducibly measuring creatinine in human whole blood obtained from a finger stick sample
Publicado el 4 de julio de 2012 · Inicio del retiro: 15 de mayo de 2012
Resumen
FDA registra el retiro Z-1903-2012 de dispositivos médicos de Clase II, publicado el 4 de julio de 2012 e iniciado el 15 de mayo de 2012. Empresa responsable: Polymer Technology Systems, Inc.; Estado: Finalizado; Cantidad reportada: 1650 vials; Lote: Cat No. 1720; and Lot number F103. La Clase II indica posibles consecuencias temporales o médicamente reversibles, o una probabilidad remota de consecuencias graves.
Estado reportado al momento de publicación: Terminated — openFDA actualiza semanalmente y este campo no refleja el estado más reciente. Confirma siempre con la fuente oficial.
Qué peligro representa
During a routine product investigation, a creatinine sample with a value less than 1.0 mg/dl was tested on a version 2.60 CardioCek PA meter and the meter provided a result of 0.08mg/dl, which is not the reportable measuring range for the CardioChek PA meter for the creatinine assay.
Qué hacer
Voluntary: Firm initiated · Letter
Recibe un correo cuando FDA publique un retiro como este
Gratis. Solo te escribimos cuando hay un retiro nuevo que coincide. Te das de baja con un clic.
Detalles del retiro
- Fabricante
- Polymer Technology Systems, Inc.
- Distribuidor
- Worldwide Distribution -- Nationwide Distribution including the states of CA and VA., and the countries of China, Poland, Ireland and France.
- Lote
- Cat No. 1720; and Lot number F103
- Clasificación de riesgo
- Class II
- Área (FDA)
- device
- País
- United States
Retiros relacionados
- FDAPTS Diagnostics CardioChek Plus Professional Analyzer, New analyzer, boxed, with carrying case, Reference29 de enero de 2020
- FDAPTS Panels CHOL+HDL+GLU Test Strips, Reference Number 5412, for use on CardioChek PA or CardioChek Plus1 de enero de 2020
- FDALipid Panel test strips (as a component of smart bundles), REF 2729, also private labeled under Henry Schein29 de mayo de 2019
- FDACHOL+HDL+GLU test strips, REF 241229 de mayo de 2019
- FDAMULTIGENT Acetaminophen for use with Architect/Aeroset Cat. No. 2K99-20. Assay is intended for the4 de julio de 2012
- FDAARCHITECT CA 19-9XR Reagent Kit; ARCHITECT CA 19-9 Reagent Kit, list 291-20 (4 x 100 tests), 2K91-25 and4 de julio de 2012
Preguntas sobre este retiro
¿PTS Panels Creatinine test strips. PTS Panels Creatinine Test Strips are intended to measure creatinine in whole blood. Creatinine measurements are used in the diagnosis and treatment of renal (kidney) diseases and in the monitoring of renal dialysis. This system is intended for the professional use for accurately and reproducibly measuring creatinine in human whole blood obtained from a finger stick sample fue retirado del mercado?
Sí. FDA publicó el retiro Z-1903-2012 el 4 de julio de 2012. Peligro reportado: During a routine product investigation, a creatinine sample with a value less than 1.0 mg/dl was tested on a version 2.60 CardioCek PA meter and the meter provided a result of 0.08mg/dl, which is not the reportable measuring range for the CardioChek PA meter for the creatinine assay.
¿Qué debo hacer si tengo este producto?
Voluntary: Firm initiated · Letter